ArticleScientific reports2019

MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells.

Patrice Cagle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.